Ausun Pharm(SH:603229) Zheng Quan Zhi Xing·2025-07-31 16:15Core Viewpoint - Zhejiang Aoxiang Pharmaceutical Co., Ltd. has announced the progress of its share repurchase plan, which aims to enhance shareholder value and implement employee stock ownership plans through the repurchase of shares [1][2]. Summary by Sections Share Repurchase Plan Overview - The share repurchase plan was first disclosed on January 27, 2025, with an implementation period from January 24, 2025, to January 23, 2026 [1]. - The expected total repurchase amount is between RMB 50 million and RMB 100 million [1]. - The repurchased shares will be used for employee stock ownership plans and/or equity incentives [1]. Progress of Share Repurchase - As of July 31, 2025, the company has repurchased a total of 1,999,400 shares, representing 0.24% of the total share capital [2]. - The total amount spent on the repurchase is RMB 15,535,845, with a price range of RMB 7.52 to RMB 8.57 per share [2]. Adjustments to Repurchase Terms - Following the annual equity distribution for 2024, the maximum repurchase price was adjusted from RMB 14 per share to RMB 13.90 per share starting July 17, 2025 [2]. Compliance and Future Actions - The company will continue to make repurchase decisions based on market conditions and will fulfill its information disclosure obligations regarding the progress of the share repurchase [3].